EMERALD HEALTH SCIENCES INC. reported 1 transaction at SKYE BIOSCIENCE, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/28/2020ACC: 0001640334-20-000163
10% Owner
Since Nov 2018
-4.08M
Net shares
Net seller
$166.46T
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
40.80M acquired · 44.88M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40.80M
Price / share
$4.08M
Trade value
$166.46T
% of position
47.6%
—
85.69M→126.49M
Total
Net shares
+40.80M
Net value
$166.46T
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | J · J | +40.80M | $4.08M | $166.46T | 47.6% | 85.69M | 126.49M |
| Total | +40.80M | $166.46T | ||||||
Derivative Transactions2
Warrant(Right to Buy)
Direct
Converts to
Common Stock
40.80M shares
Shares
−40.80M
Strike price
0.1
Held after
0.00
Exercisable
—
—
7% Convertible Debt
Direct
Converts to
Common Stock
10.20M shares
Shares
−4.08M
Strike price
0.4
Held after
5.04M
Exercisable
—
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant(Right to Buy) Direct | Common Stock40.80M shares | — | J · J | −40.80M | 0.1 | — | 0.00 |
| 7% Convertible Debt Direct | Common Stock10.20M shares | — | J · J | −4.08M | 0.4 | — | 5.04M |